Veeva Systems

If you want to measure content effectiveness, start with the right strategy, says John Postley, Boehringer Ingelheim’s senior associate director of content strategy and impact. https://lnkd.in/gQUqhHmB

I recently had the opportunity to sit down with Bonne Adams, MBA, VP of Operations at Inhibrx Biosciences, Inc., to discuss how the company is transforming its clinical operations through technology integration. Inhibrx’s innovative approach to bringing GXP systems in-house and leveraging automation has resulted in substantial quality improvements and cost savings—enabling their teams to scale more efficiently. Some key takeaways from our conversation: ? Building a strong tech foundation: Inhibrx launched six integrated software applications in just 4.5 months, which became the backbone for their clinical trials. ? Creating a culture of innovation: Executive buy-in from the top down is critical for fostering a tech-forward operational model. ? Automation for efficiency: From clinical supply distribution to AI-driven eTMF filing, automation is reducing errors and freeing up time for more critical tasks. ? Streamlining data integration: The seamless flow of data across clinical, regulatory, and safety functions is crucial for ensuring transparency and collaboration. The future of biopharmaceutical operations is undoubtedly tech-driven, and Inhibrx is leading the charge! #ClinicalTrials #Biopharma #TechInHealthcare #Automation #Inhibrx #ClinicalOperations #Innovation Veeva Systems Deivis Mercado

Leading analyst and strategic advisory firm Axendia, Inc. breaks down the industry’s shift towards unified quality and manufacturing with insights from Mike Jovanis and Jason Boyd. https://lnkd.in/emHKXppv #pharmaceuticals #manufacturing #digitaltransformation Kelly Doering Daniel Matlis

It’s great to be at #SCDM this week and see #datamanagers getting involved in the #eCOA conversation. But one theme that keeps coming up is “Why is eCOA still so challenging for study teams?” From setup to closeout, eCOA is often one of the most complex and frustrating aspects of clinical trials. But it doesn't have to be. eCOA processes need to be simplified—not only for patients and sites—but also study teams, whose challenges have been overlooked for too long. It’s time to raise the bar across the eCOA industry by reducing complexity, improving workflows, and creating a smoother, more efficient experience for everyone involved. Explore six pivotal areas for improvement in this new whitepaper:?https://lnkd.in/gDjPA3R3 Is our industry ready to take a step into the future??Let me know your thoughts below. #RaiseTheBar #ClinicalTrials

As therapies become more complex, medical affairs is emerging as a strategic pillar in the pharma industry, bridging clinical practice and patient care. In the latest issue of pharmaphorum Deep Dive, Veeva’s Dr. Christoph Bug, MD, PhD, MBA and Pascal Vande Gucht of UCB discuss the importance of measuring the impact of medical affairs activities to drive patient outcomes and improve stakeholder engagement: https://lnkd.in/eirq6fuz #medicalaffairs #medicalscienceliaison #pharmaceuticals

Axendia, Inc. recaps this month’s #VeevaSummit in Boston and shares how Veeva is unifying quality through new advancements in Veeva Batch Release and Veeva Vault LIMS. Learn more: https://lnkd.in/gtrxXANr #pharmaceuticals #manufacturing #digitaltransformation Kelly Doering Daniel Matlis

We’re thrilled to share that Manny Vazquez, CCDM has been elected as a new member of the Society for Clinical Data Management (SCDM) Board of Trustees! With 18 years of industry experience, Manny has made significant contributions, including his active involvement with clinical research sites to bring their voices to data management conversations. He’s also a proud holder of the Certified Clinical Data Manager (CCDM) certification and has been engaged with SCDM since 2016. It’s an honor to have Manny as part of the Veeva team, congratulations!

?? Join us October 11th, 10 AM EST for an exclusive webinar where Veeva Systems and industry leaders Dr. Christoph Bug, MD, PhD, MBA, Andreas Gerloff, and Pascal Vande Gucht unveil a game-changing medical impact model. With new data and insights, we’ll show how medical teams can go beyond traditional activity metrics to confidently measure and communicate their impact. Ready to take your strategy to the next level? Don't miss out! Register here: https://shorturl.at/6KfUj #Jointhemovement #MedicalAffairs #MAPSEvents

Reporting live from Boston! We’re thrilled to to support this year’s #SCDM24. Here’s a quick pic of the Veeva team. From left to right, Nicholas Klatt, Kieran Connolly, Michelle Marlborough, Eric Jacobson, Chris Kreitel, Alexis Cavalli, Katie Duzan (O'Brien), Abbie Solis, Michelle Munro, Jason Driesbaugh, Luis Torres, PMP? and Karen Klein. We would love to chat with you on how we can advance better science together. Stop by booth #405 to say hello ??, see a clinical data magic trick ??, and pick up some fun goodies to take back home ??

Hear from Marc Gabriel and Steve Gens MSOD from Gens and Associates Inc. discuss Veeva's end-to-end RIM product strategy, AI approach, and partnership with customers to continuously improve regulatory efficiency. Gens & Associates Website: https://bit.ly/3N1wRlO Spotify: https://spoti.fi/4dq7zJ0 Apple Podcasts: https://apple.co/3Zxu8Z3 #regulatoryoperations #regulatory #lifesciences